Читать книгу Biopharmaceutics - Группа авторов - Страница 18

1 [1] Levy, G. and Nelson, E. (1961). Pharmaceutical formulation and therapeutic efficacy. JAMA 177 (10): 689–691.

2 [2] Zathurecký, L. (1977). Progress in developing a standard terminology in biopharmaceutics and pharmacokinetics. Drug. Intell. Clin. Pharm. 11 (5): 281–296.

3 [3] Wagner, J.G. (1961). Biopharmaceutics: absorption aspects. J. Pharm. Sci. 50: 359–387.

4 [4] Sedo, T.K. (2020). 2019 Global drug delivery & formulation report part 1 a review of 2019 product approvals. Drug Develop. Deliv. 20 (2): 18–23.

5 [5] Amidon, G.L., Lennernäs, H., Shah, V.P., and Crison, J.R. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (3): 413–420.

6 [6] Butler, J.M. and Dressman, J.B. (2010). The developability classification system: application of biopharmaceutics concepts to formulation development. J. Pharm. Sci. 99 (12): 4940–4954.